Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Evercore ISI increased its price objective for Genuine Parts Company (GPC) to $175 from $155 and retained an Outperform rating ahead of the distributor's fourth-quarter earnings release. The firm models 2.5% organic growth and operating income ahead of consensus, and projects EPS of about $7.60 for calendar 2025 and $8.50 for 2026. The stock is tra…
Piper Sandler increased its price objective for BP to $44 from $43 and kept a Neutral rating, while the oil major paused its share repurchase program. The announcement pressured the stock, which traded around $36.97 and dropped about 6% after the buyback suspension. Piper Sandler raised near-term estimates even as BP disclosed mixed fourth-quarter …
William Blair has maintained its Outperform rating on Centrus Energy Corp. (NYSE: LEU) despite quarterly results that missed the firm's expectations and a flat 2026 guidance. The research house pointed to timing issues in legacy SWU agreements and mark-to-market uranium price effects as reasons for the shortfall, while highlighting Centrus’ strong …
Susquehanna has moved XPO from a Positive to a Neutral rating and set a $210 price target, while simultaneously boosting its 2026 and 2027 EPS forecasts. The firm cited stronger tonnage and operating leverage, particularly in XPO's LTL business, but believes upside is modest relative to the current valuation. Parallel analyst activity around Old Do…
Raymond James increased its price target on Devon Energy to $52 from $44 and kept an Outperform rating, citing the planned all-stock merger with Coterra and the combined company's scale. The deal, valued at roughly $58 billion, is expected to close around the end of the second quarter of 2024 and would give Devon shareholders about 54% of the pro f…
Melius Research downgraded BP from Hold to Sell and assigned a $31.00 price target, implying material downside from the stock's recent levels. The firm flagged BP's shift back toward oil and gas after underwhelming clean-energy ventures, leadership churn, and skepticism about the timing and durability of any operational turnaround. BP's most recent…
Susquehanna downgraded Saia Inc. from Positive to Neutral and set a $425 price target, citing valuation pressures even as the firm adjusted only its near-term earnings and raised the target multiple. The move follows Saia's mixed fourth-quarter 2025 results and comes amid differing analyst reactions from peers.
The U.S. Bureau of Labor Statistics reduced its estimate of jobs created in the 12 months through March 2025 by 862,000, revising down the seasonally adjusted change in total nonfarm employment for 2025 to 181,000 from 584,000. The benchmark revision, based on updated Quarterly Census of Employment and Wages data for the first quarter, was smaller …
PMGC Holdings' stock spiked in premarket trading after its subsidiary NorthStrive Biosciences signed a definitive license with Modulant Biosciences. The pact grants Modulant exclusive worldwide (excluding South Korea) rights to develop, manufacture and commercialize products derived from NorthStrive's EL-22 and EL-32 technologies for non-human anim…
Upstream Bio's stock dropped 23% after the company released mixed results from its Phase 2 VALIANT study of verekitug for severe asthma. Both tested dosing schedules achieved statistically significant reductions in annualized asthma exacerbation rate (AAER), but the 100mg every 12 weeks dosing produced a larger reduction and was judged more compara…
Pembina (PBA) is a cash-generative midstream operator trading near its all-time high after a run. The stock still offers an attractive 4.7% yield, reasonable valuation (PE ~21.6, PB ~2.3) and pipeline-backed growth via recent M&A and an LNG FID. We lay out an actionable long trade for income-minded investors aiming for high-single-digit upside whil…
Alan Todd Roth, Executive Regional President and Chief Operating Officer of Regency Centers Corp, sold 8,000 shares on February 10, 2026, for $616,400. The transaction occurred as the stock traded near its 52-week high, following a quarter that showed a significant EPS beat but a modest revenue miss. The company also disclosed a director retirement…
U.S. nonfarm payrolls rose by 130,000 in January while the unemployment rate slipped to 4.3% from 4.4% in December. The stronger-than-expected report reflected unusually low seasonal hiring during the holidays that reduced January layoffs, a delayed release tied to a short federal shutdown, and an updated birth-and-death model at the Bureau of Labo…
Jefferies maintained a Hold rating and a $225 price target on RTX Corp., aligning with the broader analyst consensus. The firm projects modest revenue expansion at Pratt & Whitney in 2026 and expects incremental margin gains driven by MRO capacity, automation and retrofit programs. Separate defense contracts and engine orders provide additional…
Piper Sandler lowered its price target for Lyft to $20 from $28 while holding an Overweight rating, citing weaker ride volume tied to late-quarter promotional activity. The firm still views the stock as undervalued relative to InvestingPro's Fair Value and highlighted management's guidance for bookings acceleration and EBITDA margin expansion into …
Baird lifted its price objective on Diodes (DIOD) from $60 to $80 while keeping an Outperform rating, pointing to a broader semiconductor cycle recovery and several company-level catalysts. The stock is trading at $61.70, roughly 1% below its 52-week peak, and the firm expects Diodes to remain profitable in fiscal 2025 with an EPS forecast of $1.17…
BTIG increased its price target on Walmart to $140 from $125 while keeping a Buy rating ahead of the retailer's fourth-quarter earnings release. The firm highlighted Walmart's omni-channel positioning and expanding e-commerce business as key drivers. BTIG projects fourth-quarter EPS of $0.72 and U.S. comparable-sales growth of 4.5% for the quarter …
Piper Sandler has affirmed its Overweight rating and $16.00 price target on Ford (NYSE:F) after the automaker's 2026 EBIT guidance matched market consensus. The firm highlights several execution levers that could lift results above guidance, even as Ford's latest quarterly report showed a revenue beat alongside an earnings per share shortfall.
Piper Sandler has reaffirmed an Overweight rating on Glacier Bancorp and maintained a $59.00 price target after meetings with the bank's leadership. The firm pointed to several earnings and balance-sheet tailwinds - including net interest margin expansion, organic loan and deposit growth, operating leverage and merger-and-acquisition potential - wh…
Barclays increased its price target for Coca-Cola to $83 from $77 and retained an Overweight rating, pointing to the company's stated aim of pursuing more balanced growth between price/mix and unit volumes. The firm said Coca-Cola has a straightforward set of levers to drive volume and indicated confidence in low-single-digit volume growth this yea…
Piper Sandler has reaffirmed an Overweight rating and a $30.00 price objective on Klaviyo Inc (KVYO) after the marketing automation company posted fourth-quarter 2025 results that beat expectations on several fronts. The stock, trading at $21.12, is judged undervalued by InvestingPro Fair Value metrics. Klaviyo reported stronger-than-expected reven…
Piper Sandler trimmed its price target on Robinhood Markets to $135 from $155 while retaining an Overweight rating after the company's fourth-quarter 2025 results missed revenue and adjusted EBITDA expectations. The stock fell about 9% in after-hours trading; other firms including Compass Point and Needham also adjusted targets despite continuing B…
Martin Marietta Materials posted a decline in fourth-quarter net earnings and issued a revenue outlook for 2026 that falls short of analyst expectations. While shipments and pricing benefited from demand driven by data center construction and energy and infrastructure projects, elevated costs for fuel, energy, raw materials and equipment, along wit…
Spero Therapeutics (SPRO) is a speculative buy on the thesis that Tebipenem HBr's regulatory path and clinical progress will re-rate the company from a micro-cap clinical-stage biotech to a takeout/approval candidate. The company carries limited debt, roughly $3.56M in cash on the books relative to a $133M market cap, and EV of $84.3M. This trade p…
Russia's aviation regulator said two Russian carriers will operate flights to extract Russian tourists from Cuba in the coming days, and will then suspend services to the island until a jet fuel shortage is resolved. The regulator identified the airlines as Rossiya - part of the Aeroflot group - and Severny Veter (Nordwind). The move follows Cuban …
